510(k) Report

510(k) · Cleared

Cleared

Asthma Monitor Model, AM1

K090486510(k) SpecialCleared May 6, 200970-day reviewClass II21 CFR 868.1840

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cardinal Health Germany 234 GmbH · BZG Spirometer, Diagnostic

Cleared on May 6, 2009 as substantially equivalent to K980876 (Erich Jaeger GmbH & Co. KG, 1998) after a 70-day review. Its family tree reaches back 1 generation to 1998. 14 later devices descend from it.

Decided
May 6, 2009
Review
70 days
Class
Class II
Product code
BZG
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K980876 (1998). 14 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2010: 2 descendants cleared2009: 1 descendant cleared2014: 2 descendants cleared2015: 3 descendants cleared2020: 1 descendant cleared2016: 1 descendant cleared2019: 2 descendants cleared2022: 1 descendant cleared2026: 1 descendant clearedK980876 · Asthma Monitor AM2 · Erich Jaeger GmbH & Co. KG · 19981995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 4 descendants3 generations forward: 6 descendants4 generations forward: 1 descendant5 generations forward: 1 descendant K980876 · Asthma Monitor AM2 · Erich Jaeger GmbH & Co. KG · 19980+5
  1. Root · 1 generation backK980876 Asthma Monitor AM2Erich Jaeger GmbH & Co. KG · 1998
  2. This deviceK090486 Asthma Monitor Model, AM1Cardinal Health Germany 234 GmbH · 2009
  3. Descendant · cites it directly · 9 of its ownK092324 SpiroproViasys Healthcare GmbH · 2009
  4. Descendant · 2 generations on · 6 of its ownK100687 Vitalograph Hand Held Spirometer, Model 2120Vitalograph (Ireland), Ltd. · 2010
  5. Descendant · cites it directly · 3 of its ownK092890 Asthma Monitor AM3Carefusion Germany 234 GmbH · 2010
  6. Descendant · 3 generations on · 2 of its ownK200550 Vitalograph Model 2120 In2itive eDiaryVitalograph Ireland, Ltd. · 2020
  7. Descendant · 2 generations on · 2 of its ownK133722 Asthma Monitor AM3Eresearch Technology · 2014

Showing 5 of 14 descendants. See all descendants

Descendants cleared per year

2009: 12010: 22014: 22015: 32016: 12019: 22020: 12022: 12026: 1
2009high 3 (2015) · low 0 (2011)2026

Most influential descendants

Showing 5 of 14 · See all
  • K092324SpiroproViasys Healthcare GmbH · 2009 · cites it directly9descendants
  • K100687Vitalograph Hand Held Spirometer, Model 2120Vitalograph (Ireland), Ltd. · 2010 · 2 generations on6descendants
  • K092890Asthma Monitor AM3Carefusion Germany 234 GmbH · 2010 · cites it directly3descendants
  • K200550Vitalograph Model 2120 In2itive eDiaryVitalograph Ireland, Ltd. · 2020 · 3 generations on2descendants
  • K133722Asthma Monitor AM3Eresearch Technology · 2014 · 2 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K980876Asthma Monitor AM2Erich Jaeger GmbH & Co. KG1998—
0 (this device)K090486Asthma Monitor Model, AM1Cardinal Health Germany 234 GmbH2009—
+1K092324SpiroproViasys Healthcare GmbH2009—
+2K100687Vitalograph Hand Held Spirometer, Model 2120Vitalograph (Ireland), Ltd.2010—
+1K092890Asthma Monitor AM3Carefusion Germany 234 GmbH2010—
+3K200550Vitalograph Model 2120 In2itive eDiaryVitalograph Ireland, Ltd.2020—
+2K133722Asthma Monitor AM3Eresearch Technology2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200910
201020
201420
201530
201610
201920
202010
202210
202610
FIG. 1 — Lineage of K090486, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BZG device

  1. #1 K251777 MESI mTABLET SPIROscore 13.0 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K980876Asthma Monitor AM2
Our reading of the summary gave K980676, FDA’s number for Spigal Needle (Gallini U.S., LLC). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “Asthma Monitor AM2”.
Erich Jaeger GmbH & Co. KG1998—

What descends from it? (14)

See all 14

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K092324SpiroproViasys Healthcare GmbH20099
K092890Asthma Monitor AM3Carefusion Germany 234 GmbH20103

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K092324 (Viasys Healthcare GmbH, 2009) has gone furthest, with 9 descendants of its own.

How does its category compare?

All BZG devices

BZG Spirometer, Diagnostic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · BZG

2in 2024

2007: 32008: 32009: 82010: 42011: 62012: 32013: 32014: 52015: 52016: 42017: 22018: 12019: 32020: 52021: 12022: 22023: 52024: 22026 (partial year): 1
2007high 8 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BZG

362in 2023

2007: 121 days median2008: 209 days median2009: 141 days median2010: 181 days median2011: 278 days median2012: 59 days median2013: 266 days median2014: 154 days median2015: 273 days median2016: 235 days median2019: 146 days median2020: 126 days median2023: 362 days median
2007high 362 (2023) · low 59 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BZG

1in 2024

2024: 1
2007high 1 (2024) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BZG

1in 2025

2007: 12011: 12012: 22013: 12014: 12015: 12016: 12017: 12018: 12019: 12020: 22021: 12022: 32023: 22024: 32025: 1
2007high 3 (2022) · low 0 (2008)2025

MAUDE reports naming product code BZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007312101
2008320900
2009814100
2010418100
2011627801
201235902
2013326601
2014515401
2015527301
2016423501
20172—01
20181—01
2019314601
2020512602
20211—01
20222—03
2023536202
20242—13
20250—01
20261—0—

What is it indicated for?

The Asthma Monitor AMI+ / AM1+ BT from Cardinal Health is an electronic measurement device to monitor the lung function (determination of the respiratory flows and volume) with high reproducibility wherever and whenever is a need of. The AM1+ /AM1+ BT measures the flow dudring expiration serving for the calculation of further parameters as FEV1. The AM1+ /AM1+ BT is used to monitor the respiratory status of human beings in the areas asthma, chronic…

Read the full statement (311 words)

The Asthma Monitor AMI+ / AM1+ BT from Cardinal Health is an electronic measurement device to monitor the lung function (determination of the respiratory flows and volume) with high reproducibility wherever and whenever is a need of. The AM1+ /AM1+ BT measures the flow dudring expiration serving for the calculation of further parameters as FEV1.

The AM1+ /AM1+ BT is used to monitor the respiratory status of human beings in the areas asthma, chronic obstructive pulmonary disorder and in areas like occupational medicine, clinical trials and disease management.

The patient is informed of the results by numeric values for selected parameters (e.g. PEF, FEVl). Furthermore a visual control unit, displayed as a kind of traffic lights, allows an immediate indication of the'measurement based on criteria defined by the patient's physician.

The device saves the results of a measurement (always with date and time) automatically in an internal database. The memory capacity is designed to store up to 400 measurements. In addition, a questionnaire functionality can be called up by the use of a software package (AMOS) to record e.g. the 'Quality of Life' status. When enabled, the AM1+ I AM1+ BT can be programmed with a couple of questions, where the patient can select then from a couple of different answers. This information is also stored in the internal database and can be transmitted for evaluation toa standard PC using the software package AMOS.

The AM1 + / AM1 + BT is designed to replace ordinary peak flow meter, diary and pencil by a single system. Easy handling, sturdy and handy design allow the Asthma Monitor AM1+ /AM1+ BT being used almost everywhere: at work, at home, in school, for experts opinion, research or clinical trial purposes and in occupational medicine.

The AM1+ operates with serial data transmission whereas the AM1+ BT can be operated with serial and Bluetooth data transmission.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K090486: Asthma Monitor Model, AM1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K090486

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026